VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,218,468 | -23.1% | 6,577,562 | +8.8% | 0.01% | -20.0% |
| Q2 2023 | $113,369,616 | -42.4% | 6,046,380 | -55.7% | 0.01% | +11.1% |
| Q1 2023 | $196,885,402 | +47.3% | 13,653,634 | +97.7% | 0.01% | -30.8% |
| Q4 2022 | $133,619,946 | -48.0% | 6,905,423 | -7.7% | 0.01% | -51.9% |
| Q3 2022 | $257,020,000 | +216.4% | 7,482,350 | +40.8% | 0.03% | +237.5% |
| Q2 2022 | $81,226,000 | -30.4% | 5,315,779 | +3.9% | 0.01% | -11.1% |
| Q1 2022 | $116,746,000 | -36.7% | 5,115,910 | +2.3% | 0.01% | -35.7% |
| Q4 2021 | $184,405,000 | +12.7% | 5,001,483 | +43.6% | 0.01% | +7.7% |
| Q3 2021 | $163,649,000 | -21.3% | 3,481,881 | +0.9% | 0.01% | -18.8% |
| Q2 2021 | $207,851,000 | – | 3,449,794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |